AstraZeneca, Sanofi RSV Drug Wins Backing From CDC Panel
A drug from AstraZeneca Plc and Sanofi to protect infants against a potentially fatal respiratory illness won backing Thursday from US public health advisers, moving it closer to being administered alongside other childhood immunizations. #press
